Concord Biotech announces successful completion EU GMP inspection at its API facility
This achievement underscores our unwavering commitment to upholding the highest standards of quality, safety, and regulatory compliance
This achievement underscores our unwavering commitment to upholding the highest standards of quality, safety, and regulatory compliance
Plant-based chemistries have an outsized role to play for the HPC sector by meeting demand for good, gentle, and green products
This marks the fourth acquisition by Corona Remedies from multinational corporations
The campaign celebrates radiant, healthy skin that shines naturally, empowering women to step forward with confidence in every walk of life.
The program will offer a structured and immersive learning experience for over 20,000 healthcare professionals across more than 10 cities
GII is a leading investment firm with assets under management exceeding US$ 3.5 billion with presence across Saudi Arabia, UAE, Europe, USA and India
Finerenone significantly reduced the combined risk of cardiovascular death and total (first and recurrent) heart failure events,
India’s nutraceutical industry is expected to reach over US$ 22 billion in 2025
The agreement includes plans for distribution, technology transfer, local manufacturing, new pharmaceutical product development
Subscribe To Our Newsletter & Stay Updated